Page 49 - 82_01
P. 49
Takahashi S. Diadenosine polyphosphates directly Godofredo Diéguez Castrillo
relax porcine coronary arterial smooth muscle. J
Pharmacol Exp Ther 1997;283:548–56. 216. Garcia-Dorado D, Garcia del Blanco B. Door-to-
balloon time and mortality. N Engl J Med 2014;
205. Sugimura A, Kanatsuka H, Tanikawa T, Ong BH, 370:179.
Shirato K. Effect of diadenosine tetraphosphate
(Ap4A) on coronary arterial microvessels in the 217. Position paper from the Working Group of Cellular
beating canine heart. Jpn Circ J 2000; 64:868–75. Biology of the Heart of the European Society of
Cardiology, Hausenloy DJ, Bøtker HS, Condorelli G,
206. Gawaz M. Role of platelets in coronary thrombosis Ferdinandy P, Garcia-Dorado D, Heusch G, Lecour S,
and reperfusion of ischemic myocardium. Cardiovasc van Laake LW, Madonna R, Ruiz-Meana M, Schulz
Res 2004;61:498–511. R, Joost Sluijter PG, Yellon DM, Ovize M.
Translating cardioprotection for patient benefit.
207. Kitakaze M, Sekine A, Yamaura T, Nakajima H, Hori Cardiovasc Res 2013; 98:7-27.
M. A novel endogenous vasoactive substance,
diadenosine tetraphosphate (Ap4A), produced in the 218. Takemura G, Nakagawa M, Kanamori H,
ischemic heart as a new vasodilatory mediator. Minatoguchi S, Fujiwara H. Benefits of reperfusion
Abstract. Circulation 1995;92 (Suppl. I):38. beyond infarct size limitation. Cardiovasc Res 2009;
83:269-76.
208. Garcia-Villalon AL, Monge L, Fernandez N, Salcedo
A, Narvaez-Sanchez R, Dieguez G. Coronary 219. Perricone AJ, Vander Heide RS. Novel therapeutic
response to diadenosine pentaphosphate after strategies for ischemic heart disease. Pharmacolog
ischaemia-reperfusion inthe isolated rat heart. Res2014; 89: 36-45, 2014.
Cardiovasc Res 2009; 81:336–43.
220. G. Heusch. Molecular basis of cardioprotection:
209. García-Villalón AL, Fernández N, Monge L, Granado signal transduction in ischemic pre-, post-, and remote
M, Carreño-Tarragona G, Figueras JC, Diéguez G. conditioning. Circ Res 2015; 116 (4):674-699, 2015.
Coronary response to diadenosine triphosphate after
ischemia-reperfusion in the isolated rat heart. Exp Biol 221. Murry CE, Jennings RB, Reimer KA. Preconditioning
Med (Maywood) 2012; 237 (8):966-72. with ischemia: a delay of lethal cell injury in ischemic
myocardium. Circulation 1986;74:1124–36.
210. Garcia-Villalon AL, Fernandez N, Monge L, Dieguez
G. Reduced coronary vasodilatation to diadenosine 222. Marber MS, Latchman DS, Malcolm Walker J,
tetraphosphate after ischemia-reperfusion in isolated Yellon DM. Cardiac Stress Protein Elevation 24
rat heart The FASEB J 2011;2 5:1025. Hours After Brief Ischemia or Heat Stress Is
Associated With Resistance to Myocardial Infarction.
211. García-Villalón ÁL, Granado M, Monge L, Circulation 1993;88:1264-72.
Fernández N, Carreño-Tarragona G, Amor S.
Purinergic component in the coronary vasodilatation 223. R. Bolli. The late phase of preconditioning. Circ Res
to acetylcholine after ischemia-reperfusion in perfused 2000; 87: 972-83.
rat hearts. J Vasc Res 2014;51 (4):283-9.
224. Heusch G. Cardioprotection: chances and challenges
212. Julian DG. Treatment of cardiac arrest in acute of its translation to the clinic. The Lancet. 2013; 381
myocardial ischemia and infarction. Lancet 1961; 14 (9861):166–75.
(2):840–4.
225. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang
213. Markis JE, Malagold M, Parker JA, Silverman KJ, NP, Guyton RA, Vinten-Johansen J. Inhibition of
Barry WH, Als AV, Paulin S, Grossman W, myocardial injury by ischemic postconditioning
Braunwald E. Myocardial salvage after intracoronary during reperfusion: comparison with ischemic
thrombolysis with streptokinase in acute myocardial preconditioning. Am J Physiol Heart Circ Physiol
infarction: assessment of intracoronary thallium-201. 2003; 285 (2):H579-88.
N Engl J Med 1981; 305:777–82.
226. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT,
214. Schwartz Longacre L, Kloner RA, Arai AE, Baines L'Huillier I, Aupetit JF, Bonnefoy E, Finet G, André-
CP, Bolli R, Braunwald E, Downey J, Gibbons RJ, Fouët X, Ovize M. Postconditioning the human heart.
Gottlieb RA, Heusch G, Jennings RB, Lefer DJ, Circulation2005; 112 (14):2143–48.
Mentzer RM, Murphy E, Ovize M, Ping P, Przyklenk
K, Sack MN, Vander Heide RS, Vinten-Johansen J, 227. Yellon DM, Opie LH. Postconditioning for protection
Yellon DM New horizons in cardioprotection: of the infarcting heart. Lancet2006; 367 (9509):456–
recommendations from the 2010 National Heart, Lung 458.
and Blood Institute Workshop. Circulation 2011;
124:1172–79. 228. Przyklenk K, Bauer B, Ovize M, Kloner RA,
Whittaker P. Regional ischemic ‘preconditioning’
215. Miura T, Miki T. Limitation of myocardial infarct protects remote virgin myocardium from subsequent
size in the clinical setting: current status and sustained coronary occlusion. Circulation 1993;87
challenges in translating animal experiments into (3):893–9.
clinical therapy. Basic Res Cardiol 2008; 1031:501–
12. 229. Kharbanda RK, Mortensen UM, White PA,
Kristiansen SB, Schmidt MR, Hoschtitzky JA, Vogel
48 M, Sorensen K, Redington AN, MacAllister R.
Transient limb ischemia induces remote ischemic
preconditioning in vivo. Circulation 2002; 106
@Real Academia Nacional de Farmacia. Spain
